BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37462109)

  • 1. A review of the mechanisms of blood-brain barrier disruption during COVID-19 infection.
    Jamil Al-Obaidi MM; Desa MNM
    J Neurosci Res; 2023 Nov; 101(11):1687-1698. PubMed ID: 37462109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration.
    Zhang L; Zhou L; Bao L; Liu J; Zhu H; Lv Q; Liu R; Chen W; Tong W; Wei Q; Xu Y; Deng W; Gao H; Xue J; Song Z; Yu P; Han Y; Zhang Y; Sun X; Yu X; Qin C
    Signal Transduct Target Ther; 2021 Sep; 6(1):337. PubMed ID: 34489403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Proteins - Targets for SARS-CoV-2 (Review).
    Morgun AV; Salmin VV; Boytsova EB; Lopatina OL; Salmina AB
    Sovrem Tekhnologii Med; 2021; 12(6):98-108. PubMed ID: 34796023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathophysiology of coronavirus disease 2019: neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection.
    Welcome MO; Mastorakis NE
    Inflammopharmacology; 2021 Aug; 29(4):939-963. PubMed ID: 33822324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
    Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Paracellular Permeability in SARS-CoV-2 Blood-to-Brain Transcytosis.
    Martinez TE; Mayilsamy K; Mohapatra SS; Mohapatra S
    Viruses; 2024 May; 16(5):. PubMed ID: 38793666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters.
    Hasan MR; Ahmad MN; Dargham SR; Zayed H; Al Hashemi A; Ngwabi N; Perez Lopez A; Dobson S; Abu Raddad LJ; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0078321. PubMed ID: 34730438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 infects epithelial cells of the blood-cerebrospinal fluid barrier rather than endothelial cells or pericytes of the blood-brain barrier.
    Stüdle C; Nishihara H; Wischnewski S; Kulsvehagen L; Perriot S; Ishikawa H; Schroten H; Frank S; Deigendesch N; Du Pasquier R; Schirmer L; Pröbstel AK; Engelhardt B
    Fluids Barriers CNS; 2023 Oct; 20(1):76. PubMed ID: 37875964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of renin-angiotensin system and COVID-19: the importance of daily rhythms in ACE2, ADAM17 and TMPRSS2 expression.
    Zlacká J; Stebelová K; Zeman M; Herichová I
    Physiol Res; 2021 Dec; 70(S2):S177-S194. PubMed ID: 34913351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation.
    DeOre BJ; Tran KA; Andrews AM; Ramirez SH; Galie PA
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):722-728. PubMed ID: 34687399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Term Human Placental Trophoblasts Express SARS-CoV-2 Entry Factors ACE2, TMPRSS2, and Furin.
    Ouyang Y; Bagalkot T; Fitzgerald W; Sadovsky E; Chu T; Martínez-Marchal A; Brieño-Enríquez M; Su EJ; Margolis L; Sorkin A; Sadovsky Y
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33853873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of the blood-brain barrier is correlated with spike endocytosis by ACE2 + endothelia in the CNS microvasculature in fatal COVID-19. Scientific commentary on "Detection of blood-brain barrier disruption in brains of patients with COVID-19, but no evidence of brain penetration by SARS-CoV-2".
    Magro C; Tili E; Nuovo G
    Acta Neuropathol; 2024 Feb; 147(1):47. PubMed ID: 38413411
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?
    Uversky VN; Elrashdy F; Aljadawi A; Ali SM; Khan RH; Redwan EM
    J Neurosci Res; 2021 Mar; 99(3):750-777. PubMed ID: 33217763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia alters the expression of ACE2 and TMPRSS2 SARS-CoV-2 cell entry mediators in hCMEC/D3 brain endothelial cells.
    Imperio GE; Lye P; Mughis H; Hamada H; Bloise E; Lye SJ; Matthews SG
    Microvasc Res; 2021 Nov; 138():104232. PubMed ID: 34416267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain Renin-Angiotensin System: From Physiology to Pathology in Neuronal Complications Induced by SARS-CoV-2.
    Ahmadi S; Khaledi S
    Anal Cell Pathol (Amst); 2023; 2023():8883492. PubMed ID: 37575318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.
    Wang Y; Takeshita H; Yamamoto K; Huang Y; Wang C; Nakajima T; Nozato Y; Fujimoto T; Yokoyama S; Hongyo K; Nakagami F; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Rakugi H
    FASEB J; 2021 Mar; 35(3):e21419. PubMed ID: 33566370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical and alternative receptors for SARS-CoV-2 therapeutic strategy.
    Masre SF; Jufri NF; Ibrahim FW; Abdul Raub SH
    Rev Med Virol; 2021 Sep; 31(5):1-9. PubMed ID: 33368788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis.
    Chakravarty N; Senthilnathan T; Paiola S; Gyani P; Castillo Cario S; Urena E; Jeysankar A; Jeysankar P; Ignatius Irudayam J; Natesan Subramanian S; Lavretsky H; Joshi S; Garcia G; Ramaiah A; Arumugaswami V
    FEBS Lett; 2021 Dec; 595(23):2854-2871. PubMed ID: 34757622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2.
    Krasemann S; Haferkamp U; Pfefferle S; Woo MS; Heinrich F; Schweizer M; Appelt-Menzel A; Cubukova A; Barenberg J; Leu J; Hartmann K; Thies E; Littau JL; Sepulveda-Falla D; Zhang L; Ton K; Liang Y; Matschke J; Ricklefs F; Sauvigny T; Sperhake J; Fitzek A; Gerhartl A; Brachner A; Geiger N; König EM; Bodem J; Franzenburg S; Franke A; Moese S; Müller FJ; Geisslinger G; Claussen C; Kannt A; Zaliani A; Gribbon P; Ondruschka B; Neuhaus W; Friese MA; Glatzel M; Pless O
    Stem Cell Reports; 2022 Feb; 17(2):307-320. PubMed ID: 35063125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of ACE2 and TMPRSS2 Proteins in the Upper and Lower Aerodigestive Tracts of Rats: Implications on COVID 19 Infections.
    Sato T; Ueha R; Goto T; Yamauchi A; Kondo K; Yamasoba T
    Laryngoscope; 2021 Mar; 131(3):E932-E939. PubMed ID: 32940922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.